Cite
HARVARD Citation
Berni, E. et al. (n.d.). PWE-095 Cost effectiveness of rifaximin-α 550 mg (xifaxan®/targaxan®) in the reduction of recurrence of overt hepatic encephalopathy in united kingdom. Gut. pp. A253-A254. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Berni, E. et al. (n.d.). PWE-095 Cost effectiveness of rifaximin-α 550 mg (xifaxan®/targaxan®) in the reduction of recurrence of overt hepatic encephalopathy in united kingdom. Gut. pp. A253-A254. [Online].